AbbVie Inc. (ABBV)

68.54
NYSE : Health Technology
Prev Close 68.25
Day Low/High 68.10 / 68.82
52 Wk Low/High 65.06 / 100.23
Avg Volume 8.81M
Exchange NYSE
Shares Outstanding 1.48B
Market Cap 100.90B
EPS 3.70
P/E Ratio 19.06
Div & Yield 4.28 (5.94%)

Galmed Soars on Encouraging Trial Results

Markets have perked up just a tad across the board since our last update. As mentioned in an earlier post, Galmed Pharmaceuticals is the second small-cap NASH (nonalcoholic steatohepatitis) play that has soared over the past week. The shares are up ...

When the Stock Is the Only Option

When the Stock Is the Only Option

Options spreads aren't tradable with some small biotechs, making shares the only way to play.

Surveying the M&A Landscape in Biotech

Surveying the M&A Landscape in Biotech

Who might be in play in the quarters ahead?

4 Keys to Staying Alive in Tough Markets -- And How I'm Playing 3 Big Tech Names

4 Keys to Staying Alive in Tough Markets -- And How I'm Playing 3 Big Tech Names

KLA-Tencor, Microsoft and Intel all report earnings after the close Thursday.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

Amazon and Bank of America Are 2 of 16 Stocks Poised to Change Direction

Amazon and Bank of America Are 2 of 16 Stocks Poised to Change Direction

These names are displaying signs of either bullish or bearish reversal patterns over the past week.

Some Quick Observations

Markets have improved somewhat in the past 90 minutes. The Dow and S&P 500 are now in the black with other major indices nearing even. Some quick observations about some stocks with less than two hours left to end the week. AbbVie clawing back a tad...

Jim Cramer: When There's Nothing to Buy, People Sell

Jim Cramer: When There's Nothing to Buy, People Sell

No sector offered respite from Thursday's tariff-inspired selloff.

Jim Cramer: No Place to Go and Fewer Places to Hide

Jim Cramer: No Place to Go and Fewer Places to Hide

Just not a great day.

AbbVie Appears Ready to Start a New Advance at Any Time

AbbVie Appears Ready to Start a New Advance at Any Time

Traders should still be long and looking for higher highs. Let's check the charts and indicators again.

Watch These Biotechs and the FDA Calendar

Watch These Biotechs and the FDA Calendar

Here are a few key events I will be watching closely for in the months ahead on stocks I think are buys at current levels.

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

There is nothing wrong with Intel, Johnson & Johnson, 3M and Apple.

3 Key Biotech Catalysts on the FDA Calendar

3 Key Biotech Catalysts on the FDA Calendar

A roundup of biotech names with actions pending at the FDA in coming weeks.

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.

Activating My Dip-Buying Shopping List

Activating My Dip-Buying Shopping List

I added to two positions Tuesday, as growth catalysts are in play this earnings season.

These 2 Biotech Stocks Still Have Upside

These 2 Biotech Stocks Still Have Upside

The biotech sector has seen a big rally, but there are still opportunities.

AbbVie Could Climb Even Higher

AbbVie Could Climb Even Higher

AbbVie prices are way above the rising 50-day moving average line.

Dollar Traders Believe What They See, Not What They Hear: Market Recon

Dollar Traders Believe What They See, Not What They Hear: Market Recon

Currency traders see the Trump administration boosting manufacturing via a weak dollar.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Stop Worrying About Valuations After Amazon, Alphabet and Microsoft's Earnings

Stop Worrying About Valuations After Amazon, Alphabet and Microsoft's Earnings

The revenue and profit gains from some of the biggest technology companies like Amazon AMZN, Alphabet GOOGL and Microsoft MSFT show that valuations aren't so stretched.

There Is Sound Fundamental Reasoning Behind the Positivity: Market Recon

There Is Sound Fundamental Reasoning Behind the Positivity: Market Recon

The ECB's super dovish message was good for the markets.

Alphabet, Amazon and Expedia: This Is What You Must Know on Friday

Alphabet, Amazon and Expedia: This Is What You Must Know on Friday

U.S. futures point a higher open following earnings beats from Amazon, Alphabet and Microsoft after the bell on Thursday.

AbbVie Is Likely to Correct: Book Some Profits

AbbVie Is Likely to Correct: Book Some Profits

ABBV has gone 'vertical' on the daily chart.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

This week's bullish and bearish reversal patterns.

AbbVie Reaches All-Time Highs

AbbVie Reaches All-Time Highs

Today's breakout could carry the stock sharply higher.

Earnings: Assessing 3 Biotech Bellwethers

Earnings: Assessing 3 Biotech Bellwethers

How did Celgene, AbbVie and Gilead fare last quarter?

Cramer: When Oil Falls, These Dominoes Get Hit

Cramer: When Oil Falls, These Dominoes Get Hit

It doesn't look like Washington will be much help.